New patent expiration for Wellstat Therap drug XURIDEN

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for XURIDEN
Annual Drug Patent Expirations for XURIDEN

Xuriden is a drug marketed by Wellstat Therap and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has one hundred and seventy-two patent family members in twenty-one countries.

The generic ingredient in XURIDEN is uridine triacetate. One supplier is listed for this compound. Additional details are available on the uridine triacetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top